{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_058346.4:c.Y1699C",
          "cDNA Change": {
            "transcript": "NM_058346.4",
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "c.Y1699C"
        },
        {
          "HGVS": "NM_058346.4:c.G2019S",
          "cDNA Change": {
            "transcript": "NM_058346.4",
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "c.G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0001721"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell viability assay with H2O2 exposure",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and SH-SY5Y",
        "Description": "Human embryonic kidney cells (HEK293) and human neuroblastoma cells (SH-SY5Y) were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_058346.4:c.Y1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "pathogenic",
          "Result Description": "Reduced stress tolerance and ERK pathway activation compared to wild-type."
        },
        {
          "Variant": "NM_058346.4:c.G2019S",
          "Conclusion": "Abnormal",
          "Molecular Effect": "pathogenic",
          "Result Description": "Reduced stress tolerance and ERK pathway activation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or vehicle was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not mentioned in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal stress tolerance and ERK pathway activation levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced stress tolerance and ERK pathway activation levels below normal thresholds.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "This method is commonly used in Parkinson's disease research to assess cellular responses to oxidative stress."
      }
    }
  ]
}